Health Care Archives - Page 396 of 478

6 minute read

This Legal Psychoactive Mushroom Reduces Stress And Pain And Encourages Longevity, Expert Says

October 6, 10:20 AM

This article was originally published in December 2021. Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood.

HAVLF

1 minute read

AngioDynamics Shares Fall On Lower Than Expected Q1 Earnings, Reaffirms Annual Guidance

By Vandana Singh

October 6, 10:10 AM

AngioDynamics Inc (NASDAQ: ANGO) has reported a Q1 FY23 adjusted EPS loss of $(0.06), missing the consensus EPS of $0.02 and…

ANGO

1 minute read

Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate

By Vandana Singh

October 6, 8:03 AM

Provention Bio Inc (NASDAQ:PRVB) has entered into a co-promotion agreement with Sanofi SA (NASDAQ:SNY) to launch Provention’s lead investigational candidate, teplizumab, to delay…

PRVB

1 minute read

US Judge Temporarily Blocks New Mexico & Mississippi Lawsuits Regarding J&J Talc: Report

By Vandana Singh

October 5, 3:00 PM

A U.S. bankruptcy judge has temporarily paused New Mexico and Mississippi from accusing Johnson & Johnson (NYSE: JNJ) of misleading consumers about the safety of its talc products.

JNJ

1 minute read

HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside

By Vandana Singh

October 5, 2:50 PM

HC Wainwright Matthew Caufield initiated coverage on Eyenovia Inc (NASDAQ:EYEN), focused on developing ophthalmic therapeutics based on the company’s microdose array…

EYEN

1 minute read

Acer Therapeutics Expands ACER-801 Development Into Post-Traumatic Stress Disorder

By Vandana Singh

October 5, 1:44 PM

Acer Therapeutics Inc (NASDAQ:ACER) expanded ACER-801 (osanetant) into a new indication for the reduction of the frequency and severity of acute…

ACER

1 minute read

Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids

By Vandana Singh

October 5, 1:31 PM

The FDA has accepted Takeda Pharmaceutical Co Ltd’s (NYSE:TAK) supplemental marketing application for the potential expanded use of TAKHZYRO (lanadelumab-flyo) for…

TAK

2 minute read

This Hedge Fund Scored Big Off Amazon’s Whole Foods Deal: Check Out Its 2 Dividend Stocks

By Robert Kuczmarski

October 5, 1:17 PM

Jana Partners, the activist hedge fund founded by Barry Rosenstein, grabbed headlines in 2017 when it earned $300 million off Amazon.com's (NASDAQ: AMZN) acquisition of Whole Foods.

AMZN